Status:
RECRUITING
Transcutaneous Electrical Stimulation for Stroke Patients
Lead Sponsor:
Shirley Ryan AbilityLab
Conditions:
Upper Limb Hemiparesis Following Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to evaluate the feasibility and impact of transcutaneous electrical stimulation of the spinal cord (TESS) on the recovery of post-stroke individuals who have upper limb hemiparesis. It...
Detailed Description
Upper limb (UL) hemiparesis is the most common post-stroke disability. Currently, there is no treatment used in the clinic that has shown to be efficacious for 75% of individuals who have moderate to ...
Eligibility Criteria
Inclusion
- 18 years or older
- able and willing to give written consent and comply with study procedures
- at least 6 months post-stroke
- hemiplegia secondary to stroke
- UE Fugle Meyer Assessment \<35
- not currently receiving regular occupational therapy services
- participant has received clearance from physician to participate in study
- participant has at least a rudimentary comprehension of English
Exclusion
- botox injection in upper extremity within the last 4 months
- modified ashworth score of 4 in any joint of the affected limb
- pregnant or nursing
- using a powered, implanted cardiac device for monitoring or support of heart function (i.e. pacemaker, defibrillator, or LVAD), or anti-spasticity implantable pumps, or cochlear implants
- unhealed bone fractures
- severe contractures in the upper extremities
- active cancer or cancer remission less than 5 years
- orthopedic dysfunction, injury, or surgery that would impact the individual's ability to use the upper extremities
- recent procedure or operation of the spinal cord within the past year
- traumatic brain injury or neurological conditions that would impact the study
- skull fracture that has developed within the past 6 months
- non-English speakers
Key Trial Info
Start Date :
August 18 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT06950593
Start Date
August 18 2025
End Date
January 1 2027
Last Update
August 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shirley Ryan AbilityLab
Chicago, Illinois, United States, 60611